Overview Financials News + Filings Key Docs Charts Ownership
|
|
TRINITY BIOTECH PLC (TRIB)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Cost of goods sold | 53.8% | 52.0% | 50.4% | 48.8% | 48.5% | |
| Gross profit | 46.2% | 48.0% | 49.6% | 51.2% | 51.5% | |
| Selling, general and administrative | 28.0% | 27.1% | 36.3% | 27.2% | 28.3% | |
| Research and development | 5.1% | 4.1% | 4.0% | 3.8% | 4.1% | |
| EBITDA | 16.4% | 19.2% | 11.7% | 20.8% | 20.2% | |
| Depreciation | 3.0% | 2.0% | 1.9% | | | |
| EBIT | 13.4% | 17.2% | 9.9% | 20.8% | 20.2% | |
| Pre-tax income | 22.8% | 17.2% | 11.2% | 23.5% | 23.3% | |
| Income taxes | -1.1% | -0.8% | -0.6% | -2.4% | -3.3% | |
| Net income | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
|